期刊名称：HEPATITIS Monthly
|
ISSN： | 1735-143X
|
|
出版频率： | Monthly
|
|
出版社： | KOWSAR PUBL, PATERSWEG 22,, HOENSBROEK, NETHERLANDS, LIMBURG, 6431 GC
|
|
出版社网址： | http://hepmon.com/
|
|
期刊网址： | http://hepmon.com/
|
|
影响因子： | 1.932(2015) |
| 主题范畴： | GASTROENTEROLOGY & HEPATOLOGY |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
A quarterly Official Journal compiled by Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, Iran and Iran Hepatitis Network.
- This journal is approved by Minister's Deputy Office in Press and Publicity Affairs of Ministry of Culture and Islamic Guidance according to certificate number 124/2420 on 20 August 2007 as International Quarterly Medical Journal.
- This journal is approved by The Iranian Committee of Medical Science Journals of Ministry of Health and Medical Education according to certificate number 159950 on 26 August 2007 as Scientific Research Medical Journal.
Aim and Scope
Hepatitis Monthly is a clinical journal officially published by Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IRAN which is informative to all practicing gastroenterologists, hepatologists, infectious disease specialists, and internists.
This authoritative clinical journal is founded in 2002 by Professor Seyed Moayed Alavian. The Journal context is devoted to particular compilation of the latest worldwide and interdisciplinary approach and findings including original manuscripts, meta-analyses and reviews, health economic papers, debates and consensus statements of clinical relevance of hepatological field especially liver diseases.
In addition, consensus evidential reports not only highlight the new observations, original researches and results accompanied by innovative treatments and all the other relevant topics but also include highlighting disease mechanisms or important clinical observations and letters on articles published in journal.
Indexing Sources:
Our journal is indexed by:
Also, Hepatitis Monthly has acknowledged in The Cochrane Library and Hepato-Biliary group.
Scientific collaborators: Hepatitis Monthly is published in co-operation with:
Instructions to Authors
| New Guidelines for Authors |
| In order to improve the number of admissions and more success to publish articles, authors can see and download sample of checklists which is the base for Reviewers in the review process. These files are as follows according to the type of articles. |
|
|
Hepatitis Monthly publishes original articles, clinical challenges, review articles, research reports, case reports, letters and meeting reports every three months. The papers in all fields of liver diseases, especially viral hepatitis which will assist the practitioners in making clinical decisions and virologists to conduct basic research, are welcomed.
It is noteworthy that Hepatitis Monthly is currently indexed in several worldwide known directories of Science Citation Index Expanded (SCIE), Web of Sciences, Thomson Reuters (ISI), WHO-EMRO Index Medicus, DOAJ, CABI and Highwire
Submission
Hepatitis Monthly recommends you to send your articles through our online submission system, easy to use and easy to track, thus by conducting all procedures electronically your submission will be done rather faster. Keep our website in mind: www.hepmon.ir. Once you submit an article it will be forwarded to one of the editors at least and one of the peer-reviewers to have it reviewed and evaluated.
At once after submission, the author will be notified of both the submission process by means of Email and the follow-up code. It is recommended to save the sent code for all the future correspondence regarding each article separately. For those who prefer posting manuscripts, the mailing address is P.O Box 19395-5487, Tehran, IR. Iran.
In the cover letter, authors (or the corresponding author on behalf of all authors) should state that the manuscript, or part of it, has not been and will not be published elsewhere or submitted elsewhere for publication.
Manuscript preparation
To send electronically, manuscripts should be in Word Document or Rich Text Format. Manuscripts, well-written in English, should follow the style of the agreement detailed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, a copy of which can be found at http://www.icmje.org. Manuscripts sent in other languages or poorly-written make an extra charge for translation or revision which shall be paid by author(s). Please double check the article for spelling, structure and format mistakes. What follows is a series of recommendations on how the article should be like in order to process it faster and more efficiently.
Conflict of Interest
To prevent the information on potential conflict of interest for authors from being overlooked or misplaced, the information to be a part of the cover letter is essential.
Ethics of Experimentation/Informed Consent
The cover letter must include a statement declaring that the study complies with current ethical considerations.
Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient included in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee.
In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
Title page
All the following should be clearly stated on the title page:
Title: choose a title that is long enough to cover the main points and by considering the importance of shortness
Author(s): full name of all authors should be mentioned.
Institution(s): all institutions should be written for each author.
Corresponding author: one of the authors should be picked out for possible correspondence before and after publication. Their address, telephone number and email should be written.
Support: sources of any supports should be mentioned.
Running title: a shorter version of the title (40 characters at most) is needed for page footer.
Word counts: especially for long articles, it is necessary to mention the total number of words.
Abstract and keywords
An abstract of 250-300 words should be provided to state the reason for the study, the main findings and the conclusions drawn from the observation. Abstract of original articles and brief reports should be structured under the following headings: background and aims, methods, results and conclusions. A list of 3-10 keywords must be provided for indexing purposes.
Article
The rest of the article differs according to the article type you are submitting but generally includes the following headings: introduction, materials and methods, results, discussion and references.
Introduction: This should summarize the purpose and the rationale for the study. It should neither review the subject extensively nor should it have data or conclusions of the study.
Materials & Methods: This should include exact method or observation or experiment. If an apparatus is used, its manufacturer's name and address should be given in parenthesis. If the method is established, give reference but if the method is new, give enough information so that another author is able to perform it. If a drug is used, its generic name, dose and route of administration must be given. Statistical method must be mentioned and specify any general computer programme used. The Info system used should be clearly mentioned.
Results: It must be presented in the form of text, tables and illustrations. The contents of the tables should not be all repeated in the text. Instead, a reference to the table number may be given. Long articles may need sub-headings within some sections (especially the Results and Discussion parts) to clarify their contents.
Discussion: This should emphasize the present findings and the variations or similarities with other work done in the field by other workers. The detailed data should not be repeated in the discussion again. Emphasize the new and important aspects of the study and the conclusions that follow from them. It must be mentioned whether the hypothesis mentioned in the article is true, false or no conclusions can be derived.
Acknowledgements: All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. It should include persons who provided technical help, writing assistance and departmental head who only provided general support. Financial and material support should also be acknowledged.
Tables: All tables must be included within the text of the manuscript in the appropriate section (i.e. in introduction, materials and methods, results or discussion). Please do not put the tables at the end of the manuscript and do not upload them as separate files.
Figures: All figures, charts and so forth come at the end of the article with references in the article. Figures should be uploaded as separate PNG, JPEG, or GIF files.
Letters to the editor:
Letters to the editor will be considered if they give significant comments on recent articles published in Hepatitis Monthly or they contain relevant preliminary data providing new insights. Letters need no abstract, should be no more than 400 words, must cite the previous article in Hepatitis Monthly that is being discussed, and should have no more than five references.
Brief report:
Report sorts should not exceed 750 words and should contain a structured abstract of 150 words maximum. Short reports should comprise sections of Introduction, Materials & Methods, Results and Discussion with not more than 2 tables or figures and up to 10 references.
Clinical Challenge:
Clinical challenges present a striking clinical image that is meant to challenge and inform readers and to illustrate and teach important medical points and the diagnosis and discussion should make an important medical teaching point. Clinical challenges need no abstract but should include 3 to 5 references.
Health Policy Challenge:
Health policy challenge identify and discuss important issues of hepatitis and liver diseases, linked to health policies of a country or region as well as analysis of social, economical, ethical and political issues. Health policy challenge should normally not be more than 2500 words with an unstructured abstract of no more than 150 words.
References
References should be numbered and listed in order of appearance in the text. Cite the names of all authors when there are six or fewer; when seven or more, list the three followed by et al. Names of journals should be abbreviated in the style used in Index Medicus.
Journal
Einollahi B, Hajarizadeh B, Bakhtiari S, et al. Pre-transplant hepatitis C virus infection and its effect on the post-transplant course of renal allograft recipients. J Gastroenterol Hepatol 2003;18 :836-840
Book
Roberts NK. The Cardiac Conducting System and the His Bundle Electrogram. Appleton-Century-Crofts, New York, 1981; 49-56
Chapter in a book
Kitchen AD, Barbra JAJ. Prevention. In: Zuckerman AG, Thomas HC. Viral Hepatitis. 2nd edition. Churchill Livingstone, Edinburgh: 1998; 347-56
Fonts
To distinguish different parts of the article, it is recommended to use the font Times New Roman size 12 for the body, size 12 bold for subheadings, size 14 for headings and size 14 bold for the title.
Proofs: Proofs will be sent to the corresponding author. Galley proofs should be returned within 72 hours from receipt with clear indication of any changes.
Review Process: All submitted manuscripts are examined by the Editorial Board and sent to two or three peer-reviewers. The reviewers are masked as to the identity of the authors and their affiliation. Authors are usually notified within 2-3 months about the acceptability of their manuscript. On receiving reviewers’ comments, authors are requested to send the revised article, and a copy of their reply to the reviewers, including the comment and explaining the replies to questions and changes made to the revised version.
To make sure your article meets all the requirements, please use the following checklist.
□ Full names and affiliates of all authors are added.
□ Corresponding author is determined.
□ Email, mailing address, telephone numbers (fixed, mobile and fax) are added.
□ Names of all institutions involved in the project are mentioned.
□ Conflict of interest and ethical consideration have been clearly stated.
□ Title is short and informative.
□ Abstract does not exceed the limit.
□ 3-10 keywords are picked.
□ Body has introduction, materials and methods, results, discussion, and conclusion.
□ References are put in the right place through the text as superscript in parentheses.
□ References follow the style described in the ‘manuscript preparation’ section.
□ Copyright form has been signed by all authors and mailed or faxed.
Editorial Board
Chairman
Kamran Bagheri Lankarani, Professor of Gastroenterology and Hepatology, Shiraz, Iran
Founder & Editor-in-Chief
Seyed-Moayed Alavian, Professor of Gastroenterology and Hepatology, Tehran, Iran
Managing Editors
Mehrdad Nooranipour, M.D., Research Associate of Hepatology, Tehran, Iran
Hadi Karimzadeh, M.Sc., Research Associate of Hepatology, Tehran, Iran
Associate Editors (A-Z)
Peyman Adibi Iran
Samad Amini-Bavil-Olyaee Germany
Saeid Ghavami Canada
Mohammad Hossein Somi Iran
Marek J.Los Canada
Fariborz Mansour-Ghanaei Iran
Marc Van Ranst Belgium
Babak Sayad Iran
Stephan Schaefer Germany
Frank Tacke Germany
Editorial Board (A-Z)
Zaigham Abbas, M.D., Associate Professor, Karachi, Pakistan
Abdul. Ghani Mohamed Ali Hasani Al. Samarai, M.D., Professor of Dermatology & Sexually Transmitted Diseases and Clinical Virology, Tikrit, Iraq
Farhat Abbas Bhatti, M.D., Associate Professor of Pathology, Karachi, Pakistan
Majid Bouzari, Ph.D., Department of Biology, Isfahan, Iran
Bill Carman, Ph.D. Professor of Clinical Virology, Glasgow, UK
Heng Chen, Ph.D., Associate Professor, Shanghai, CHINA
Harry R. Dalton, M.D., Professor, Truro, UK
Nasser Ebrahimi Daryani, Ph.D., Professor of Gastroenterology, Tehran, Iran
Azza Abdel Hamid El Sherbini, M.D., Tanta, Egypt
Atefeh Ghanbari Khanghah, M.D., Assistant Professor, Rasht, Iran
Ali Akbar Haghdoost, M.D., Ph.D., Assistant Professor of Epidemiology and Biostatistics, Kerman, Iran
Mehrdad Hasibi, M.D., Associate Professor of Infectious Diseases, Tehran, Iran
Abtin Heidarzadeh, M.D., Assistant Professor of Social Medicine, Rasht, Iran
Hamidreza Honarmand, Ph.D., Assistant professor of microbiology, Rasht, Iran
Seyed-Mohammad-Mehdi Hosseini-Moghadam, M.D., Associate Professor of Infectious Diseases, Tehran, Iran
Reza Jafari Shakib, M.D., Ph.D., Assistant professor of immunology, Rasht, Iran
Seyed Mohammad Jazayeri, M.D., Ph.D., Clinical Virology, Tehran, Iran
Hossein Khedmat, M.D., Associate Professor of Gastroenterology and Liver Diseases, Tehran, Iran
Geng Tao Liu, M.D., Professor of Pharmacology, Beijing, China
Lars Magnius, M.D., Ph.D., Professor, Stockholm, Sweden
Seyed-Amir Mirbagheri, M.D., Associate Professor of Gastroenterology and Liver Disease, Tehran, Iran
Seyyed Mohammad Miri, M.D., Baqiyatallah Research Center for Gastroenterology and Liver Disease, Tehran, Iran
Amir Houshang Mohammad-Alizadeh, M.D., Associate Professor of Gastroenterology and Liver Diseases, Tehran, Iran
Helen Norder,, Ph.D., Associate Professor of Infectious Diseases, Stockholm, Sweden
Morteza Pourahmad, M.D., Assistant Professor of Infectious Diseases, Jahrom, Iran
Michael Roggendorf, Ph.D., Professor of Virology, Essen-Holsterhausen, Germany
Mohammad Rostampour, Ph.D., Assistant Professor of Faculty of Medicine, Rasht, Iran
Farzaneh Sabahi, Ph.D., Virology, Medical Sciences, Tehran, Iran
Mehdi Sabei-Firoozi, M.D., Professor of Gastroenterology and Liver Diseases, Shiraz, Iran
Ramin Sarrami-Forooshani, Ph.D. Fellow, University of Alberta, Canada
Pedro Lopez Saura, M.D., Ph.D., Professor, Havana, Cuba
Batool Sharifi-Mood, M.D., Associate Professor of Infectious Diseases, Zahedan, Iran
Ahmad Shavakhi, M.D., Assistant Professor of Gastroenterology and Liver Diseases, Isfahan, Iran
Rasoul Tabari Khomeiran, Ph.D., Assistant Professor, Rasht, Iran
Christian Trepo M.D., Ph.D, Professor of Hepatogastroenterology, Lyon, France
Takuya Watanabe M.D., Ph.D, Assistant Professor of Internal Medicine and Gastroenterology, Niigata, Japan
Ralf Weiskirchen, Ph.D., Aachen, Germany
Javed Yakoob, M.D., Assistant Professor, Karachi, Pakistan
Yun-Qing Yao, M.D., Ph.D., Professor in Science of Infectious Diseases and Hepatology, Chongqing, China
Wen Zhili, M.D., Associate Professor of Hepatology, Nanchang, China
Fangcheng Zhuang, Ph.D., Associate Professor of Medical Virology and Clinical Epidemiology, Hangzhou, China
Address of Editorial Board
Hepatitis Monthly: Scientific Research Journal, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Ground Floor of Baqiyatallah Hospital, Mollasadra Ave., Vanak Sq., Tehran, Iran
Tel/Fax: +98-21-81262072; P.O.Box: 19395-5487
E-Mail: editor@hepmon.ir
Consultant Committee (A-Z)
Somayeh Abodollahi Sabet, M.D., Tehran, Iran
Mehdi Abouzari, M.D., Tehran, Iran
Arezoo Aghakhani, M.D., Tehran, Iran
Masoud Ahmadzad Asl, M.D., Tehran, Iran
Seyed-e-Hoda Alavian, M.D., Tehran, Iran
Mostafa Alavi-Moghaddam, M.D., Tehran, Iran
Neda Ashayeri, M.D., Tehran, Iran
Majid Avijgan, M.D., Isfahan, Iran
Kourosh Azimi, M.D., Tehran, Iran
Sepeideh Besharati, M.D., Guilan, Iran
Naser Baligh, M.D., Tehran, Iran
Bita Behnava, M.D., Tehran, Iran
Farzaneh Esna-ashari, M.D., Tehran, Iran
Mohammad-Sadegh Fallah, M.D., Tehran, Iran
Sara Farhang, M.D., Tabriz, Iran
Ebrahim Fattahi, M.D., Tabriz, Iran
Gholam Ali Ghorbani, M.D., Tehran, Iran
Zahra Goodarzi, M.Sc., Tehran, Iran
Behzad Hajarizadeh, M.D., Tehran, Iran
Bashir Hajibeigi, M.D., Tehran, Iran
CAI Hao Dong, M.D., Beijing, China
Mohammad Hashemi, Ph.D., Zahedan, Iran
Vahid Hoghooghi, Pharm.D., Tehran, Iran
Seyyed Mohammad Javad Hosseini, IM.D., Tehran, Iran
Reyhaneh Jafarshad, M.D., Guilan, Iran
Younes Jahani, Ph.D., Tehran, Iran
Nematollah Jonaidi Jafari, M.D., Tehran, Iran
Farahnaz Joukar, M.Sc., Rasht, Iran
Ali Kabir, M.D., Tehran, Iran
Manoochehr Karami, M.Sc., Kermanshah, Iran
Pegah Karimi Elizee, M.D., Tehran, Iran
Maryam Keshvari, M.D., Tehran, Iran
Ali Reza Khoshdel, M.D., Ph.D., Tehran, Iran
Nastaran Mahboobi, M.D., Tehran, Iran
Yousef Najian, M.D., Tehran, Iran
Mehrdad Nooranipour, M.D., Tehran, Iran
Ali OmraniRad, M.D., Tehran, Iran
Hossein Poustchi, M.D. Ph.D., Tehran, Iran
Mahdi Rezai, M.D., Tehran, Iran
Saeed Safari, M.D., Tehran, Iran
Kobra Salami Kohan, M.D., Guilan, Iran
Mahmood Salesi, Ph.D., Tehran, Iran
Shahnaz Sali, M.D., Tehran, Iran
Mahtab Shabani, M.D., Tehran, Iran
Hafiz Muhammad Shafique, F.C.P.S., Rawalpindi, Pakistan
Saeid Shahraz, M.D., MA, USA
Ahmad Reza Shamshiri, M.D., Tehran, Iran
Konrad L. Streetz, Ph.D., Achen, Germany
Vahid Tabatabaei, M.D., Tehran, Iran
Saeed Taheri, M.D., Tehran, Iran
Maryam Vaezjalali, Ph.D., Tehran, Iran
Babak Yektaparast, M.D., Tehran, Iran
Mitra Zandi, M.D., Tehran, Iran
Language Editors
Hamid-Reza Tavangar, M.D.
Mohsen Reza Heidari, M.D.
Rocky Citro, M.S.W.
Christopher Boyle, B.A.
Executive Committee
Mehdi Ashour, Head
Farshid Alvandi
Ehsan Ameri
Amir Amini-Bavil-Olyaee
Bent-al-Hoda Beyram
Hossein Irani
Seyed-e-Mahtab Najafi
|
